Nonfatal overdose among heroin users in southwestern China

American Journal of Drug and Alcohol Abuse

Volumn 33, Issue 4, 2007, Pages 505-516

  Yin, Lu ^a   Qin, Guangming ^b   Ruan, Yuhua ^a,f   Qian, Han Zhu ^c,f   Hao, Chun ^a   Xie, Lianzhi ^d   Chen, Kanglin ^d   Zhang, Yafeng ^d   Xia, Yaowen ^d   Wu, Junlin ^d   Lai, Shenghan ^e   Shao, Yiming ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b SICHUAN CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c University of Alabama at Birmingham   (United States)

^d Xichang Center for STD and Leprosy Control   (China)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f MT 645 ^*  (China)

Author keywords

China; Heroin user; Methadone; Nonfatal overdose

Indexed keywords

BENZODIAZEPINE; DIAMORPHINE; METHADONE; NALOXONE;

ADULT; ARTICLE; CHINA; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG OVERDOSE; FEMALE; HEROIN DEPENDENCE; HUMAN; INJECTION; INTERVIEW; LOGISTIC REGRESSION ANALYSIS; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PERSONAL EXPERIENCE; PREVALENCE; PRISON; RISK FACTOR; STATISTICAL SIGNIFICANCE;

ADULT; CAUSE OF DEATH; CHINA; FEMALE; HEROIN; HEROIN DEPENDENCE; HUMANS; LOGISTIC MODELS; MALE; METHADONE; MULTIVARIATE ANALYSIS; OVERDOSE; PREVALENCE; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 34547566958     PISSN: 00952990     EISSN: 10979891     Source Type: Journal    
DOI: 10.1080/00952990701407223     Document Type: Article

References (31)

1. Degenhardt L, Hall W, Warner-Smith M. Using cohort studies to estimate mortality among injecting drug users that is not attributable to AIDS. Sex Transm Infect 2006; 82:iii56-63.
2. Bargagli AM, Hickman M, Davoli M, Perucci CA, Schifano P, Buster M, Brugal T, Vicente J. COSMO European Group. Drug-related mortality and its impact on adult mortality in eight European countries. Eur J Public Health 2006; 16:198-202.
3. Krentz HB, Kliewer G, Gill MJ. Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003. HIV Med 2005; 6:99-106.
4. Darke S, Zador D. Fatal heroin 'overdose': A review. Addiction 1996; 91:1765-1772.
5. Miller CL, Kerr T, Strathdee SA, Li K, Wood E. Factors associated with premature mortality among young injection drug users in Vancouver. Harm Reduct J 2007; 4:1.
6. Ribeiro M, Dunn J, Sesso R, Dias AC, Laranjeira R. Causes of death among crack cocaine users. Rev Bras Psiquiatr 2006; 28:196-202.
7. Pollini RA, McCall L, Mehta SH, Celentano DD, Vlahov D, Strathdee SA. Response to overdose among injection drug users. Am J Prev Med 2006; 31:261-264.
8. McGregor C, Darke S, Ali R, Christie P. Experience of non-fatal overdose among heroin users in Adelaide, Australia: Circumstances and risk perceptions. Addiction 1998; 93:701-711.
9. Heale P, Dietze P, Fry C. Deliberate overdose among heroin overdose survivors. J Urban Health 2003; 80:230-237.
10. Darke S, Williamson A, Ross J, Mills KL, Havard A, Teesson M. Patterns of nonfatal heroin overdose over a 3-Year period: Findings from the Australian treatment outcome study. J Urban Health 2007; 84:283-291.
11. Sergeev B, Karpets A, Sarang A, Tikhonov M. Prevalence and circumstances of opiate overdose among injection drug users in the Russian Federation. J Urban Health 2003; 80:212-219.
12. Aceijas C, Stimson GV, Hickman M, Rhodes T; United Nations Reference Group on HIV/AIDS Prevention and Care among IDU in Developing and Transitional Countries. Global overview of injecting drug use and HIV infection among injecting drug users. AIDS 2004; 18:2295-2303.
13. Chu TX, Levy JA. Injection drug use and HIV/AIDS transmission in China. Cell Res 2005; 15:865-869.
14. Lu F, Wang N, Wu Z, Sun X, Rehnstrom J, Poundstone K, Yu W, Pisani E. Estimating the number of people at risk for and living with HIV in China in 2005: Methods and results. Sex Transm Infect 2006; 82:iii87-iii91.
15. Qian HZ, Schumacher JE, Chen HT, Ruan YH. Injection drug use and HIV=AIDS in China: Review of current situation, prevention and policy implications. Harm Reduct J 2006; 3:4.
16. Zhang L, Ruan YH, Jiang ZQ, Yang ZN, Liu SZ, Zhou F, He YX, Yin L, Qin GM, Shao YM. A 1-year prospective cohort study on mortality of injecting drug users. Zhong Hua Liu Xing Bing Xue Za Zhi 2005; 26:190-193.
17. Gossop M, Griffiths P, Powis B, Williamson S, Strang J. Frequency of non-fatal heroin overdose: Survey of heroin users recruited in non-clinical settings. BMJ 1996; 313:402.
18. Powis B, Strang J, Griffiths P, Taylor C, Williamson S, Fountain J, Gossop M. Self-reported overdose among injecting drug users in London: Extent and nature of the problem. Addiction 1999; 94:471-478.
19. Pollini RA, McCall L, Mehta SH, Vlahov D, Strathdee SA. Non-fatal overdose and subsequent drug treatment among injection drug users. Drug Alcohol Depend 2006; 83:104-110.
20. Seal KH, Kral AH, Gee L, Moore LD, Bluthenthal RN, Lorvick J, Edlin BR. Predictors and Prevention of Nonfatal overdose among street-recruited injection heroin users in the San Francisco Bay Area, 1998-1999. Am J Public Health 2001; 91:1842-1846.
21. Sergeev B, Karpets A, Sarang A, Tikhonov M. Prevalence and circumstances of opiate overdose among injection drug users in the Russian Federation. J Urban Health 2003; 80:212-9.
22. Sporer KA, Kral AH. Prescription naloxone: Novel approach to heroin overdose prevention. Ann Emerg Med 2007; 49:172-7.
23. Darke S, Ross J, Hall W. Overdose among heroin users in Sydney, Australia: I. prevalence and correlates of non-fatal overdose. Addiction 1996; 91:405-411.
24. Brugal MT, Barrio G, De LF, Regidor E, Royuela L, Suelves JM. Factors associated with non-fatal heroin overdose: Assessing the effect of frequency and route of heroin administration. Addiction 2002; 97:319-327.
25. Darke S, Hall W, Weatherburn D, Lind B. Fluctuations in heroin purity and the incidence of fatal heroin overdose. Drug Alcohol Depend 1999; 54:155-161.
26. Odegard E, Amundsen EJ, Kielland KB. Fatal overdoses and deaths by other causes in a cohort of Norwegian drug abusers-A competing risk approach. Drug Alcohol Depend 2007; 89:176-182.
27. Stewart D, Gossop M, Marsden J. Reductions in non-fatal overdose after drug misuse treatment: Results from the National Treatment Outcome Research Study (NTORS). J Subst Abuse Treat 2002; 22:1-9.
28. O'Driscoll PT, McGough J, Hagan H, Thiede H, Critchlow C, Alexander ER. Predictors of accidental fatal drug overdose among a cohort of injection drug users. Am J Public Health 2001; 91:984-987.
29. Brugal MT, Domingo-Salvany A, Puig R, Barrio G, Garcia de Olalla P, de la Fuente L. Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids in a cohort of heroin users in Spain. Addiction 2005; 100:981-989.
30. Davoli M, Perucci CA, Forastiere F, Doyle P, Rapiti E, Zaccarelli M, Abeni DD. Risk factors for overdose mortality: A case-control study within a cohort of intravenous drug users. Int J Epidemiol 1993; 22:273-277.
31. Lugo RA, Satterfield KL, Kern SE. Pharmacokinetics of methadone. J Pain Palliat Care Pharmacother 2005; 19:13-24.